1. [Comment from the cardiologic viewpoint].
- Author
-
Lüscher TF
- Subjects
- Atorvastatin, Cardiovascular Diseases mortality, Female, Fluorobenzenes administration & dosage, Heptanoic Acids therapeutic use, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors administration & dosage, Hypolipidemic Agents therapeutic use, Male, Pravastatin therapeutic use, Primary Prevention, Pyrimidines administration & dosage, Pyrroles therapeutic use, Randomized Controlled Trials as Topic, Risk Factors, Rosuvastatin Calcium, Simvastatin therapeutic use, Sulfonamides administration & dosage, C-Reactive Protein analysis, Cardiovascular Diseases prevention & control, Cholesterol, LDL blood, Fluorobenzenes therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Pyrimidines therapeutic use, Sulfonamides therapeutic use
- Published
- 2009
- Full Text
- View/download PDF